Tag: White House

CHC_general2

Movement in White House-Pharma Industry Standoff on Drug Pricing?

CHC_Legislative1

FDA in Line for Major Budget Increase in Federal Budget Deal

CHC_general1

White House Drug Pricing Initiative Could Include Moves on Generics/Biosimilars, Demonstration Projects and an End to Part D Rebates, Rawson Says